CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit

NEW YORK, July 25, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of CVS Health Corporation (NYSE: CVS) between May 3, 2023 and April 30, 2024. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by September 10, 2024.

For more information, and to join the CVS Health Corporation class action, go to https://rosenlegal.com/submit-form/?case_id=24975 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected].

The Rosen Law Firm is investigating Allegations that CVS Health Corporation (NYSE: CVS) Misled Investors Regarding its Business Operations.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the forecasts CVS used to determine plan premiums were ineffective at accounting for medical cost trends and health care utilization patterns; (2) as a result, CVS was likely to incur significant expenses to cover cost increases that were not accounted for in the CVS' forecasts and thus not covered by plan premiums; (3) accordingly, CVS had overstated the profitability of its Health Care Benefits segment; (4) contrary to defendants' assurances, the revenues generated from CVS' other primary segments were insufficient to offset the negative financial impact of the increasing expenditures within the Health Care Benefits segment; and (5) as a result, CVS' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

What Now: You may be eligible to participate in the class action against CVS Health Corporation. The deadline to file a motion to be appointed as lead plaintiff is September 10, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, go to https://rosenlegal.com/case/cvs-health-corporation/.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      www.rosenlegal.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-investors-have-opportunity-to-lead-cvs-health-corporation-securities-fraud-lawsuit-302206906.html

SOURCE THE ROSEN LAW FIRM, P. A.